The catalytic (C) and regulatory (R) subunits of protein kinase A are exceptionally dynamic proteins. Interactions between the R-and C-subunits are regulated by cAMP binding to the two cyclic nucleotide-binding domains in the R-subunit. Mammalian cells express four different isoforms of the R-subunit (RI␣, RI␤, RII␣, and RII␤) that all interact with the C-subunit in different ways. Here, we investigate the dynamic behavior of protein complexes between RI␣ and C-subunits using small angle x-ray scattering. We show that a single point mutation in RI␣, R333K (which alters the cAMP-binding properties of Domain B) results in a compact shape compared with the extended shape of the wild-type R⅐C complex. A double mutant complex that disrupts the interaction site between the C-subunit and Domain B in RI␣, RI␣ AB R333K⅐C(K285P), results in a broader P(r) curve that more closely resembles the P(r) profiles of wild-type complexes. These results together suggest that interactions between RI␣ Domain B and the C-subunit in the RI␣⅐C complex involve large scale dynamics that can be disrupted by single point mutations in both proteins. In contrast to RI␣⅐C complexes. Domain B in the RII␤⅐C heterodimer is not dynamic and is critical for both inhibition and complex formation. Our study highlights the functional differences of domain dynamics between protein kinase A isoforms, providing a framework for elucidating the global organization of each holoenzyme and the cross-talk between the R-and C-subunits.
PKA is a ubiquitous Ser/Thr kinase that phosphorylates numerous proteins, eliciting diverse biological responses including learning, memory (1), metabolism (2) , and cell death (3) . In the absence of cAMP, PKA is an inactive tetramer composed of two catalytic (C) subunits bound to a dimer of regulatory (R) subunits. Binding of two cAMP molecules to each R-subunit releases two catalytically active C-subunits.
There are four PKA R-subunit isoforms (RI␣, RI␤, RII␣, and RII␤), and all share the same domain organization. All of the R-subunits contain an N-terminal dimerization/docking domain that interacts with anchoring proteins, an inhibitor sequence that binds to the C-subunit active site, and two tandem cAMP-binding domains (designated Domains A and B). Despite these commonalities, each isoform differs in its cellular and tissue-specific distribution, abundance, sequence, structure, and biochemical properties. Moreover, each isoform is functionally nonredundant. Only RI␣ subunits are embryonically lethal (4, 5) , and mutations in RI␣ are associated with Carney complex (6 -8) and systemic lupus erythematosus (9, 10) . Given the biological differences between the PKA isoforms and their relevance to disease, it is important to characterize their molecular properties more rigorously to better understand their functional differences.
The PKA-I␣ holoenzyme crystal structure described by Kim et al. (11) illuminated the detailed interactions between the Cand RI␣-subunits and elucidated a molecular mechanism for the ordered and cooperative activation of PKA by cAMP. Both the structure and mutational data highlighted the role of Domain B as the gatekeeper domain for Domain A. cAMP first binds to Domain B, triggering a conformational change that enables cAMP to bind to Domain A. This second cAMP binding step releases the active C-subunits (12) . The first conformational change in RI␣ involves reorientation of the two cAMPbinding domains, induced by structural changes in the ␣B and ␣C helices connecting Domains A and B (Fig. 1) . In the C-subunit-bound conformation, the ␣B and ␣C helices combine to form a single contiguous helix (␣B/C), producing an overall dumbbell-shaped structure where the two domains are separated (Fig. 1A, left panel) . In the cAMP-bound conformation, the ␣B/C helix is divided into three sections, producing an overall compact globular structure where the two domains share a common interface (Fig. 1A, right panel) . Fig. 1B compares the changes in the ␣B and ␣C helices when RI␣ shuttles between the cAMP-bound and C-subunit-bound conformations. In the cAMP-bound conformation, the ␣B and ␣C helices form distinct segments with residues Gly 235 and Tyr 244 serving as two hinge points. In contrast, these same two residues are engaged to form the continuous helix in the C-subunit-bound conformation. These structural comparisons highlight the dynamic nature of the two domains within the RI␣-subunit and show that the conformational transition between the active (cAMP-bound) and inactive (C-subunit-bound) states consists of large scale domain motions around two hinge points.
During efforts to crystallize the PKA-I␣ holoenzyme complex, parallel crystallization trials were set up for three RI␣ deletion mutants (RI␣ AB , RI␣ AB R209K, and RI␣ AB R333K, where RI␣ AB refers to the truncated form of RI␣ 91-379 containing both cAMP-binding domains) in complex with the C-subunit. Only the holoenzyme formed with RI␣ AB R333K produced crystals that diffracted to 2.2 Å. Arg 333 is essential for high affinity binding of RI␣ to cAMP in Domain B (the corresponding residue in Domain A is Arg
209
). This residue is located within the phosphate-binding cassette of RI␣ (residues 199 -211 and 323-335 for Domains A and B, respectively), and its side chain forms a hydrogen bond with the cAMP phosphate (Fig. 1B, right panel) . The R333K mutation was first identified in S49 mouse lymphoma cells (13) and was shown to diminish the ability of PKA to respond to cAMP (14) . Our study addresses the effects of the R333K mutation on the global architecture of the RI␣⅐C complex in solution.
Previous small angle x-ray scattering (SAXS) data showcased differences in the overall shape of holoenzymes formed with truncated RI-and RII-subunits (15) (16) (17) . In these R-subunit constructs, the N-terminal dimerization domains were removed so that only R⅐C heterodimers were monitored. The RII␣⅐C and RII␤⅐C heterodimers formed compact, globular particles, whereas the RI␣⅐C heterodimer exhibited a more elongated shape that produced a P(r) curve with a broad shoulder in the high r region. Although the source of the extended tail has not been unequivocally determined, we hypothesize that it is due to extension of a highly dynamic Domain B in RI␣ (18) .
Here, we focus on four main questions: 1) In the RI␣ P(r) curve, is the shoulder at the high r region due to Domain B? 2) Is the large scale domain organization of RI␣ altered within the R⅐C complex when mutations are introduced into either Domain A or B? 3) Can mutations at particular sites in the C-subunit be utilized to disrupt a specific interface in the R⅐C complex, and can SAXS detect these changes? 4) Finally, can we interpret and account for the SAXS differences between RI-and RII-subunits as a result of variations in the overall organization of the cAMP-binding domains and/or differences in the cross-talk between the R-and C-subunits? Answers to these questions should provide insights into how the diversity between R-subunit isoforms give rise to the unique and sophisticated mechanisms of isoform-specific PKA regulation in cells.
To test our hypothesis that Domain B in PKA-I␣ is highly flexible and the effects of the R333K mutation on this flexibility, we utilized a combination of site-directed mutagenesis, biochemical analysis, and small angle x-ray scattering to better understand the role of Domain B dynamics in PKA-I␣ complexes. The SAXS results reported here show that heterodimers formed with the RI␣ AB R333K mutant display a different SAXS profile from wild-type RI␣ AB and that these differences stem from Domain B. Our data also indicate that in RI␣, Domain B is dynamic even when complexed with the C-subunit. In contrast to RII␤ where Domain B is essential for C-subunit interactions, the interaction of Domain B from RI␣ with the C-subunit is dispensable for holoenzyme formation.
EXPERIMENTAL PROCEDURES
Protein Preparation-The catalytic subunit was expressed and purified in Escherichia coli BL21 (DE3) cells (Novagen) as described previously (19) . Expression and purification of the C-subunit mutant K285P followed the same protocol. All of the RI␣ proteins (RI␣ A , RI␣ AB , RI␣ AB R209K, and RI␣ AB R333K, where RI␣ A and RI␣ AB refers to constructs corresponding to residues 91-244 and 91-379, respectively) were expressed and purified as described previously (20) .
Holoenzymes of RI␣ mutants (RI␣ A , RI␣ AB , RI␣ AB R209K, and RI␣ AB R333K) were formed by mixing each R-subunit with wild-type C-subunit in a 1:1.2 molar ratio and then dialyzing overnight at 4°C in 10 mM MOPS (pH 7.0), 50 mM NaCl, 2 mM MgCl 2 , 2 mM dithiothreitol, and 0.5 mM ATP. Each holoenzyme complex was separated from excess C-subunit by gel filtration chromatography. Care was taken to concentrate samples immediately prior to SAXS data collection because these complexes were extremely prone to aggregation at concentrations higher than 5 mg/ml. SAXS Data Collection-Small angle x-ray scattering measurements were collected at the University of Utah with an Anton Paar SAXSess instrument with line collimation and an image plate detector. The protein samples were concentrated to 2-5 mg/ml and filtered (0.22 m) immediately prior to data collection. Scattering data for protein samples and their respective solvent blanks were collected in a 1-mm diameter quartz capillary with a 10-mm beam slit at 12°C.
SAXS Data Analysis-Normalized buffer subtraction and data reduction to I(q) versus q (where q ϭ (4 sin)/, 2 is the scattering angle, and is the wavelength of radiation, 1.54 Å) were performed with the program SAXSquant1D (Anton-Paar, Austria). Radius of gyration (R g ) and zero angle scattering (I(0)) parameters were calculated using both GNOM (21) and by Guinier analysis with the program PRIMUS (22) . Inverse Fourier transform calculations of I(q) to yield P(r) functions, I(0), R g , and the maximum dimension (D max ) were carried out using a q range of 0.013-0.17 1/Å. CRYSOL was used to calculate theoretical scattering intensity from Protein Data Bank coordinates of R⅐C crystal structures (23) . The figures were made in PyMOL (DeLano Scientific LLC, San Carlos, CA).
Amino Acid Analysis-Amino acid composition of each R⅐C complex was determined after SAXS data collection to accurately quantify protein concentrations. Amino acid analysis was performed by Dr. Dennis Winge at the University of Utah. The molecular weight (MW) of each complex was determined experimentally with the relation I(0) ϭ ϰ*MW 2 *c, where I(0) is the scattering at zero angle, ϰ is a proportionality constant, and c is the concentration as determined by amino acid analysis. I(0) was determined by GNOM, and the proportionality constant, ϰ, was determined using lysozyme as a protein standard.
Structural Models-Ab initio shape restoration with the program DAMMIF (24) was used to generate three-dimensional structures from the one-dimensional scattering data of all seven PKA complexes. No symmetry constraints were applied, and default parameters were used in each calculation. Ten independent models for each heterodimer complex were generated, then aligned, and averaged using the program DAMAVER (25) . DAMMIF models for RI␣ A ⅐C and RI␣ AB R333K⅐C complexes were aligned with their respective crystal structure coordinates (Protein Data Bank codes 3FHI and 2QCS, respectively) using the program SUPCOMB (26) .
Determination of Binding Kinetics by Surface Plasmon Resonance-Binding experiments were performed on a Biacore 3000 instrument (GE Healthcare). Purified wild-type and K285P mutant C-subunits were diluted to 10 -50 g/ml in 10 mM potassium phosphate buffer (pH 6.0), 20 mM NaCl, 1 mM ATP, and 10 mM MgCl 2 . These proteins were immobilized onto CM5 Sensor Chips (GE Healthcare) via amine coupling to a ligand density response of ϳ300 response units (RU). Dilutions of RI␣ AB ranging from 0.5 to 250 nM were prepared in 10 mM HEPES (pH 7.4), 150 mM NaCl, 0.0005% (v/v) surfactant P-20 (HBS-P buffer; GE Healthcare), 1 mM dithiothreitol, 1 mM ATP, and 10 mM MgCl 2 . Each RI␣ concentration was injected into the channels at a flow rate of 50 l/min. The surface was regenerated with 200 M cAMP and 2 mM EDTA in HBS-P buffer. Sensograms were analyzed using Biaevaluation software version 4.1 (GE Healthcare) to obtain kinetic parameters. Sensogram curves were fit to a 1.1 binding model.
Inhibition of C-subunit by RI␣-The inhibition assay was carried out as described earlier (27) . Briefly, C-subunit wild-type or K285P mutant proteins were incubated with varying concentrations of RI␣ AB for 30 min at 30°C. Each reaction mix contained 0.5-1 mM of the substrate peptide Kemptide (LRRASLG), 1-2 nM C-subunit, and 0.5 mM ATP. R-subunit was serially diluted to final concentrations ranging from 0.5 to 500 nM. The reactions were initiated with a mixture of Kemptide, ATP, and [␥-
32 P]ATP, allowed to proceed for 20 min at 30°C, and then quenched with 30% acetic acid. Free [␥-32 P]ATP was separated from protein-bound radioactivity by ascending chromatography on phosphocellulose p81 Whatman paper as described previously (28) . Phosphate incorporation into Kemptide was detected by Cerenkov counting on a Beckman LS 6000SC liquid scintillation system. Curve fitting and IC 50 calculations were performed using GraphPad Prism 5 software (GraphPad, San Diego, CA).
RESULTS
SAXS data were collected for seven PKA-I␣ holoenzyme complexes formed with a combination of four different RI␣ mutants (termed RI␣ A , RI␣ AB , RI␣ AB R333K, and RI␣ AB R209K) and two C-subunit proteins (wild type and K285P mutant; the RI␣ AB R209K⅐C(K285P) complex was not examined). To study the contribution of the two cAMP-binding domains on PKA-I␣ dynamics, we used RI␣ constructs RI␣ 91-244 and RI␣ 91-379 , which lacked the N-terminal dimerization domain and the linker region. The minimal sequence required to form a high affinity complex with the C-subunit includes the inhibitor sequence region (residues 91-100) and Domain A (residues 120 -244). The SAXS intensity plots of I(q) versus q, Guinier plots, and associated distance distribution P(r) functions are shown in Figs. 2 and 3. Guinier plots for all samples were linear at the low q range, indicative of monodisperse solutions with no presence of nonspecific aggregation during data acquisition. Because each sample contained monodisperse particles, these data were suitable for structural analysis. The intensity curves were fit, and inverse Fourier transforms were performed using the program GNOM (21) to generate P(r) curves.
RI␣ Heterodimers-To assess the general shape characteristics of RI␣ AB ⅐C heterodimers containing both Domains A and B, we measured the SAXS profiles of RI␣ AB and wild-type C-subunit complexes ( Fig. 2A) . The P(r) functions for RI␣ AB ⅐C are similar to previous data from our laboratory (16) , where a single peak with a maxima at 35 Å is followed by a long extended tail at the high r range. In the present experiments, the maximum dimension, D max (105 Å), and R g values (29.4 Ϯ 0.1 and 32.4 Ϯ 0.8 Å, from Guinier and GNOM analysis, respectively) are somewhat smaller than previously reported (D max ϭ 120 -130 Å and R g values ϭ 36.4 -38.6 Å) (16) . These differences are most likely due to differences in sample handling or variations from one preparation to the next as was noted in our previous report (16) . In the present study, we were careful to concentrate samples immediately prior to data collection to minimize possible aggregation.
Effect of Deleting Domain B-To assess the contribution of Domain B to the overall shape of the heterodimer, we measured the x-ray scattering of a complex formed with RI␣ containing only one of the two cAMP-binding domains (RI␣ residues 91-244, RI␣ A ). This protein is the smallest fragment of RI␣ that still binds to both cAMP and the C-subunit with high affinity. The resulting P(r) function resembles a spherical, globularshaped particle with a symmetrical Gaussian curve and no indication of the broad shoulder at the high r region detected in the RI␣ AB ⅐C complexes (Fig. 2B) . The D max measured by SAXS was 70 Å, consistent with the maximum dimensions determined from the crystal structure solved with the same constructs (29) . In addition to differences in the P(r) curve, both the D max and R g values for RI␣ A are smaller than for RI␣ AB (Table 1) . Thus, not only does Domain B contribute to the overall size of the complex, it also contributes to the broad shoulder observed in the RI␣ AB ⅐C P(r) function.
Effect of R333K on RI␣ Heterodimers-In contrast to the extended P(r) curve observed with the wild-type RI␣ AB ⅐C heterodimer, the P(r) function for the RI␣ AB R333K⅐C heterodimer displays a Gaussian distribution typical of a globular, spherical particle (Fig. 3A) . GNOM analysis reveals a P(r) function with a peak maximum at 35 Å that goes to zero at a D max of 83 Å and an R g value of 28.4 Ϯ 0.4 Å (the R g was estimated to be 28.3 Ϯ 0.9 Å by Guinier analysis). The extended tail at the high r region in the RI␣ AB ⅐C heterodimer data is not detected in RI␣ AB R333K⅐C. Both the D max and R g values are smaller for RI␣ AB R333K⅐C complexes compared with RI␣ AB heterodimers without the R333K mutation. Moreover, PKA heterodimers formed with RI␣ AB R333K DECEMBER 18, 2009 • VOLUME 284 • NUMBER 51 resemble the more compact shapes observed with RII heterodimers (16) .
Domain Dynamics of PKA-I␣
The crystal structure of the PKA-I␣ complex was solved using the R333K mutant, RI␣ AB R333K⅐C. We hypothesized that the R333K mutation trapped the R-subunit into a compact conformation enabling favorable crystal packing necessary to achieve crystals that diffract to Ͻ3 Å. To assess the validity of the crystallographically observed conformation in light of our solution scattering studies, we calculated the theoretical scattering intensities from atomic coordinates of the RI␣ AB R333K⅐C structure (Protein Data Bank code 2QCS) using the program CRYSOL (23) and generated a P(r) function based on this theoretical scattering data. The experimental and calculated P(r) curves are both very symmetrical without any significant tail at long r values (Fig. 4) . Furthermore, both D max and R g values are in excellent agreement between the two data sets. Clearly, the experimental and calculated SAXS data closely overlap, confirming that the overall shape of the RI␣ AB R333K⅐C complex measured in solution is very consistent with what is observed in the crystal structure.
Based on the SAXS data of wild-type and RI␣ AB R333K⅐C heterodimers, the overall shape of these complexes are undoubtedly distinct (Fig. 3A) . Although the P(r) functions of wild-type RI␣ AB ⅐C heterodimers have a broad tail at long vector lengths, both experimental and calculated P(r) functions of RI␣ AB R333K⅐C heterodimers do not. The shoulder originates from Domain B because removal of this entire domain in RI␣ A ⅐C complexes yield symmetrical P(r) curves. Clearly, the overall shape of the wild-type heterodimer in solution as observed by SAXS is not consistent with the static image presented in the RI␣ AB R333K⅐C crystal structure. In solution, the wild-type RI␣ AB ⅐C complex likely exists as an ensemble of conformational states ranging from compact to extended. The conformation observed in the crystal structure represents only one of many possible states available for the wild-type RI␣ AB ⅐C heterodimer in solution. We propose that when bound to the C-subunit, the R333K mutation pushes the equilibrium state of RI␣ toward a dumbbell shape (Fig. 1A, left panel) , resulting in a very compact R⅐C complex. The SAXS data suggest that in the absence of the R333K mutation, RI␣ is more dynamic and spends a significant fraction of time in an extended conformation.
Effect of R209K on RI␣ Heterodimers-The R333K mutation impairs cAMP binding to Domain B, and the corresponding mutation for Domain A is R209K. To test whether this mutation also affects the dynamics of the R-and C-subunit interaction, we measured the x-ray scattering of R⅐C heterodimers formed with R209K. Unlike the R333K mutation, the P(r) function for R209K⅐C shows little difference in the overall shape compared with the wild-type R⅐C heterodimer (Fig. 3B) . The P(r) function has a maximum peak at 34.7 Å, a D max of 105 Å, and an R g value of 34.6 Ϯ 0.4 Å (33.5 Ϯ 0.9 Å from Guinier analysis; Table 1 ). Clearly, the compaction of the R⅐C complex is specific only to the R333K mutation in Domain B. 
Effect of the K285P Mutation on RI␣ Heterodimers-The
PKA-I␣ holoenzyme crystal structure defined a novel interaction site between Domain B of RI␣ and a short S-shaped loop (␣H-␣I loop) in the C-subunit (see Fig. 6, A and B) to proline reduced the ability of RII␤ to inhibit C-subunit activity (27) , providing biochemical evidence that Domain B (in the R-subunit) and ␣H-␣I loop (in the C-subunit) interaction site is important for at least the RII␤ isoform. Bioinformatics analysis has also pinpointed a short segment within the ␣H-␣I loop (Gly 282 -Gly 286 ) to be a conserved AGC kinase-specific insert (Fig. 6B, left panel) whose function has yet to be fully elucidated (31) .
To specifically block Domain B in RI␣ from interacting with the C-subunit, we utilized the C-subunit mutation, K285P. To assess the effect of the K285P mutation on the solution structure of the RI␣ AB heterodimer complex, we compared the x-ray scattering profiles of complexes formed with wild-type and mutant K285P C-subunits. Indeed, the P(r) functions of both RI␣ AB ⅐C and RI␣ AB ⅐C(K285P) complexes show very similar profiles where a single peak is followed by a long extended tail at the high r region (Fig. 2A) . The maximum dimension of each complex was roughly the same (105 and 106 Å for wild-type and K285P C-subunits, respectively). Furthermore, the R g values were similar for both proteins (32.4 and 34.1 Å for wild type and K285P, respectively).
We predicted that the x-ray scattering of R⅐C heterodimers formed with the RI␣ A protein and the K285P mutant would be identical to wild-type C-subunit because the absence of Domain B in RI␣ A eliminates the R-subunit interaction site with Lys 285 in the C-subunit. Indeed, the P(r) functions are indistinguishable for RI␣ A complexes formed with wild-type and K285P C-subunits (Fig. 2B) .
For the RI␣ AB R333K⅐C heterodimer, we investigated whether the compact nature of the complex would be disrupted by interfering with the interaction site between Domain B and the large lobe of the C-subunit using the C(K285P) mutant. Indeed, the RI␣ AB R333K⅐C(K285P) double mutant complex no longer exhibits the compact symmetric P(r) curve observed with RI␣ AB R333K⅐C (Fig. 3A) . Instead, the P(r) curve exhibits an extended tail at the high r region, similar to but not as pronounced as in the wild-type R⅐C heterodimer. Comparison of D max and R g parameters between wild-type and K285P heterodimers show remarkable overlap. Both the double mutant complex and wild-type heterodimer have a D max of ϳ105 Å, and the R g of the double mutant is 31.4 Ϯ 0.3 Å compared with 32.4 Ϯ 0.8 Å for RI␣ AB ⅐C. SAXS scattering parameters for all wild-type and mutant R⅐C heterodimer complexes are summarized in Table 1 . The inability of the K285P C-subunit mutant to fully recapitulate the solution structure of the wild-type R⅐C heterodimer probably indicates that the RI␣ AB R333K mutant still retains some effect on R⅐C interactions that prevents Domain B from exploring the full conformational space accessible to the wild-type RI␣ AB ⅐C complexes.
Biochemical Analysis of RI␣ and RII␤ Heterodimers-
The previous data show that the K285P mutant played a pivotal role in RII␤ inhibition of the C-subunit; however, the R⅐C binding constants were not measured (27) . Given the differences in SAXS profiles between RI␣ AB ⅐C and RII␤ AB ⅐C heterodimers, we postulated that the K285P mutation would not affect either the inhibition or binding affinities between RI␣ and the C-subunit.
Surface plasmon resonance was used to measure the binding constants between the R-and C-subunits. C-subunits were immobilized to CM5 chips by amine coupling, and RI␣ AB was flowed across the chip surface. Compared with wild-type C-subunit, the K285P mutant exhibited a modest 5-fold decrease in binding affinity between the RI␣ AB and C-subunits. The K D was 4.9 nM for the K285P complex compared with 0.9 nM for the wild-type R⅐C complex (Table 2 ). In contrast, the K285P mutation caused a 38-fold decrease in binding affinity for the RII␤⅐C heterodimer, where the K D was 2.9 and 111 nM between RII␤ and wild-type C-subunit and C(K285P) mutant, respectively. The difference between the binding constants is solely attributed to differences in the dissociation rate.
We also used a 32 P incorporation protein kinase assay to measure the ability of RI␣ to inhibit both wild-type and mutant C-subunits. There was no statistically significant difference between wild-type and K285P C-subunit inhibition by RI␣, where the IC 50 was 2 Ϯ 1 and 3 Ϯ 1 nM, respectively (Fig. 5) .
DISCUSSION
Proteins are in continuous motion, constantly sampling different conformations. Although crystallography provides high resolution information, this technique does not guarantee that the conformational state of the crystallized protein is representative of the predominant conformational state under physiological conditions and can be occasionally plagued by artificial conformations induced by crystal packing. To fully understand the intrinsic behavior of RI␣⅐C complexes, solution techniques must also be utilized. In this study, we analyzed PKA-I␣ heterodimers using a combination of SAXS and biochemical analysis to investigate domain dynamics within the protein complexes. SAXS is highly advantageous in that it provides low resolution structural information under a variety of solution-based physiological conditions and can be used to obtain size and shape information of large, highly dynamic proteins and protein complexes. Here, we compare our results to previous high resolution crystallographic data to obtain a more complete understanding of the large scale conformational dynamics of PKA. To explore the dynamics of Domain B in PKA-I␣ holoenzyme complexes, we measured the equilibrium R⅐C dissociation constants, the inhibition of the C-subunit by the R-subunit, and the overall shape of various mutant RI␣⅐C complexes by small angle x-ray scattering. The most pronounced result of our study is that a single point mutation, R333K, alters the solution structural properties of PKA-I␣ holoenzymes, presumably through effects on large scale dynamics of Domain B. The calculated x-ray scattering curve of the RI␣ AB R333K⅐C crystal structure is very consistent with our experimental SAXS results, indicating that the solution conformation of the RI␣ AB R333K⅐C heterodimer is very similar to what is observed in the RI␣ AB R333K⅐C crystal structure. Our SAXS data clearly indicate a large difference in the overall molecular shape between wild-type RI␣ AB ⅐C and RI␣ AB R333K⅐C heterodimers. Differences in these solution structures likely arise from variations in domain dynamics within the two complexes, particularly with respect to Domain B. We postulate that Domain B in the RI␣ AB R333K⅐C heterodimer forms a stable interaction with the C-subunit via the ␣H-␣I loop, but in wild-type RI␣, Domain B interactions with the C-subunit are more transient, giving rise to the shoulder observed in the P(r) profiles. The RI␣ AB R333K⅐C crystal structure revealed a previously unidentified single contact point between the ␣B helix in Domain B of RI␣ and the ␣H-␣I loop in the C-subunit (Fig.  6A) . We examined whether the interaction between the C-subunit ␣H-␣I loop and the RI␣ Domain B observed crystallographically remains stable in solution or whether Domain B might have a more dynamic behavior in the PKA-I␣ complex. Lys 285 in the C-subunit ␣H-␣I loop operates as a helix cap for the R-subunit ␣B helix (Fig. 6B, right  panel) , so we utilized the C-subunit mutation K285P as a strategy for disrupting the R⅐C interaction at the Domain B interface. K285P was first identified in a yeast genetic screen (32) and was shown to reduce the ability of RII␤-subunits to inhibit C-subunit catalytic activity (27) . If the interaction between Domain B (in RI␣) and ␣H-␣I loop (in the C-subunit) interface is stable as observed in the crystal structure, the K285P mutation would be expected to affect the overall shape characteristics in the RI␣ AB R333K⅐C complex. In contrast, if the Domain B interaction with the C-subunit in wildtype RI␣ AB ⅐C complexes is not stable, the K285P should not affect the binding affinities or inhibition. Indeed for RI␣ AB ⅐C(K285P) complexes, we found that K285P did not affect the general size or shape characteristics (Fig. 2) or inhibition by RI␣ (Fig. 5) and had only modest effects on the binding affinity ( Table 2 ).
The only differences between K285P and wild-type C-subunit were seen in complexes formed with the RI␣ AB R333K mutant. The P(r) curve for the RI␣ AB R333K⅐C shows that it assumes the most compact shape of all the RI␣ complexes, which is presumably why crystallization of this complex (and not the wild type) was successful. SAXS analysis of RI␣ AB R333K⅐C(K285P) reveals a P(r) curve with a slightly extended tail at the high r region, but not to the large extent observed in RI␣ AB ⅐C complexes. In other words, although the K285P mutation partially disrupted the interaction between Domain B and the C-subunit, it did not completely restore the full dynamic range of the wild-type heterodimer, suggesting that the average conformational state of Domain B in the RI␣ AB R333K⅐C(K285P) complex is intermediate between the fully compact form observed in the RI␣ AB R333K⅐C crystal and solution structures and the more extended RI␣ AB ⅐C heterodimer solution structure.
The RI␣ AB R333K⅐C crystal structure highlights two additional ion pairs at the Domain B site: Asp
276C
:Arg 352R and Thr 278C :Arg 355R (Fig. 6B, right panel) . These two interactions may partially compensate for the release of the Lys 285C /Arg
355R
and Lys 285C /Leu 357R interactions, thereby allowing for transient stabilization of Domain B against the C-subunit. The shoulder at 90 -105 Å observed in the RI␣ AB ⅐C P(r) curve likely stems from Domain B because the P(r) function becomes completely symmetrical upon removal of Domain B entirely in the RI␣ A ⅐C complex (Fig. 2B) . Given that the shoulder in the P(r) curve is only a small component, and the first peak at ϳ35 Å is the dominant component, the RI␣ AB ⅐C complex is most likely a dynamic ensemble of conformational states where Domain B is mostly associated with the C-subunit but is detached from the C-subunit in a small fraction of complexes at any given time. This hypothesis is consistent with hydrogen-deuterium exchange mass spectrometry data where only 1 of 11 amides are protected in the ␣H-␣I loop of the RI␣ AB ⅐C complex (33) .
Our SAXS results indicate that Domain B in RI␣ explores a large conformational space when bound to the C-subunit. Although the precise motion of Domain B within RI␣⅐C complexes is not clear, we speculate that the flexibility stems from a hinge motion in some portion of the ␣B/C helix that connects the two cAMP-binding domains (Fig. 1) . Analysis of various crystal structures demonstrates that RI␣ can adopt a large range of conformations. When RI␣ is bound to the C-subunit, the ␣B and ␣C helices are extended into one contiguous helix. When RI␣ is bound to cAMP, the same ␣B/␣C helix is divided into three distinct helices separated by two bends at Gly 235R and Tyr 244R . There is a 22 Å difference in the maximum dimension between the most compact (RI␣ AB R333K⅐C) and the most extended (RI␣ AB ⅐C) heterodimer, most likely because of hinge motions at the Gly 235R position. Gly 235R forms a hinge point at the C terminus of the ␣B helix (residues 226 -235). This ␣B helix forms a hydrophobic interface with the C-subunit through Leu 233R and Met 234R in the R-subunit, and mutation of either residue permits activation of holoenzymes at lower cAMP concen-FIGURE 6. Model of Domain B motions in the PKA-I␣ complex. A, crystal structure of the RI␣ AB R333K⅐C complex highlighting the interaction between RI␣ Domain B and the C-subunit (gray box). The small lobe of the C-subunit is in white, and the large lobe is in brown. The R-subunit Domain A is in dark teal, Domain B is in light teal, and the ␣B/C helix is depicted as a red cylinder in the right panel. B, left, the region between the ␣H-␣I loop of the C-subunit (residues 282-287) is an insert specific to AGC kinases. Right, detailed illustration of the interaction between RI␣ Domain B and the C-subunit ␣H-␣I loop. C, left, modeled movement of Domain B within the RI␣ AB ⅐C complex. Domain B was rotated manually using residues Gly 235 and Tyr 244 as the hinge points. Right, simulated P(r) curves for the four different models. Theoretical scattering curves of each model were calculated using CRYSOL, and their corresponding P(r) curves were generated using GNOM. The experimental data for RI␣ AB R333K⅐C (red) and RI␣AB⅐C (gray) are shown for comparison. D, averaged and filtered DAMMIF models for the seven PKA-I␣ heterodimers. The DAMMIF models for RI␣ A ⅐C and RI␣ AB R333K⅐C complexes are superimposed onto the crystal structure models (Protein Data Bank accession numbers 3FHI and 2QCS, respectively). The experimental scattering data (colors) were fit to the scattering curve calculated for the DAMMIF structure (black) in the graph in the bottom right panel. Wild-type (WT) C-subunit complexes are shown as solid symbols, and K285P C-subunit mutants are shown as open symbols. The colors for each curve are identical to colors for the DAMMIF models.
trations, 3 suggesting that this region is strongly anchored to the C-subunit in wild-type proteins.
To test our hypothesis that hinge motions are responsible for the extended structures seen in the wild-type RI␣ AB ⅐C heterodimer, we took a computational approach and artificially introduced kinks at the Gly 235R and Tyr 244R hinge points of the RI␣ AB R333K⅐C crystal structure and computed their scattering intensities and corresponding P(r) functions (Fig. 6C) . Movement of Domain B away from the C-subunit resulted in larger R g values, larger particle dimensions, and the presence of a shoulder at higher r values. Although the extended tail in these modeled P(r) functions is present in each curve, they are not as pronounced as the experimental data for the wild-type RI␣ AB ⅐C complex. Previous modeling of scattering data with the programs DAMMIN (34) and CONTRAST (35) do show that Domain B is positioned far from the C-subunit (16) . Our efforts in computing ab initio three-dimensional shapes for each of the seven PKA-I␣ mutant complexes resulted in an array of molecular structures (Fig. 6D) . The DAMMIF results for the RI␣ A ⅐C complex resulted in the most globular shape and superimposed very well with the crystal structure model (Protein Data Bank code 3FHI). The RI␣ AB R333K⅐C complex with the additional Domain B resulted in a compact structure as well and also superimposed very well with the crystal structure (Protein Data Bank code 2QCS). In contrast, the DAMMIF envelope predictions for the remaining complexes (RI␣ AB ⅐C, RI␣ AB ⅐C(K285P), RI␣ AB R333K⅐C(K285P), and RI␣ AB R209K⅐C) all exhibited elongated shapes. These results corroborate our hypothesis that in the wild-type R⅐C complex, Domain B in RI␣ is mobile in solution and samples an assortment of conformational states.
In light of data from other studies, it is apparent that the function of Domain B in RI␣ is not to provide high affinity binding to the C-subunit but to facilitate cAMP-dependent activation of the holoenzyme. Deletion of Domain B from RI␣ results in 500-fold higher concentrations of cAMP required to activate the holoenzyme and does not impair the ability of the remaining RI␣ structure to bind the C-subunit with high affinity (36) . Similarly, preventing cAMP access to Domain B with the R333K mutation increases the activation constant for cAMP from 166 to Ͼ1500 nM (12) . Collectively, these data are in agreement with the notion that Domain B is dispensable for stable RI␣⅐C complex formation. Instead, the role of Domain B in RI␣ is to enhance activation of the RI␣⅐C complex in response to cAMP.
From our data and others, it is unmistakable that the role of Domain B differs between RI-and RII-subunits. First, the activation of RI␣⅐C is a stepwise process where cAMP must bind to Domain B before Domain A (12) . For RII␤, sequential binding of cAMP is not required for activation, where cAMP binding to either domain is sufficient to release catalytically active C-subunits (37) . Second, Domain B contributes to high affinity binding between RII␤ AB and the C-subunit, but not between RI␣ AB and the C-subunit. Disruption of the interaction interface by the K285P mutation in the C-subunit resulted in a 38-fold decrease in K D for RII␤, versus a modest 5-fold decrease in K D for RI␣, suggesting that K285P is not critical for RI␣⅐C complex formation but is significant for RII␤⅐C formation. Third, previous studies demonstrated that the K285P mutation reduced the ability of RII␤ to inhibit the C-subunit and was sufficient to completely abolish BCY1 (the yeast homolog of mammalian RII subunits) inhibition of the C-subunit (27) . Fourth, based on data from hydrogen/deuterium exchange-mass spectroscopy experiments, the ␣H-␣I loop is well protected in the RII␤⅐C complex (33, 37) , whereas minimal protection is seen in the RI␣⅐C complex (30) . Lastly, SAXS analysis of the RII␤⅐C complex shows a P(r) curve that reflects a compact particle (16) , corroborating the view that Domain B forms a tight interaction with the C-subunit.
In this study, SAXS, in conjunction with mutagenesis and solution-based biochemical techniques, provides insights into domain dynamics within PKA complexes that are not feasible with x-ray crystallography alone. Taken together, our data suggest different roles of Domain B in RI␣ and RII␤. For RII␤, not only does Domain B interact tightly with the C-subunit, it is also necessary for inhibition of the C-subunit. In contrast, for RI␣, Domain B is highly mobile, and its interaction with the C-subunit ␣H-␣I loop is not necessary for inhibition, but Domain B is essential for the highly cooperative process of cAMP-dependent activation. Given the sequence and overall structural similarity between the four isolated R-subunit PKA isoforms, it is surprising that their dynamic behaviors differ in the context of holoenzyme complexes, giving rise to unique and sophisticated modes of cAMP-mediated activation. RI holoenzymes are finely tunable multimeric complexes that require a sequential series of events, unlike RII holoenzymes. Our investigation of protein dynamics in RI⅐C and RII⅐C heterodimers provides yet another layer of complexity that distinguishes the molecular features between PKA isoforms. From a global perspective, these structural distinctions give rise to the functionally nonredundant roles each isoform performs within the cell.
